Will I lose weight on 2.5mg Mounjaro — and what should I realistically expect?

You've just started Mounjaro and the scales haven't moved much

Picture this: you ordered your first Mounjaro pen, it arrived the next working day, you gave yourself the first injection, and two weeks later you step on the scales expecting something dramatic. The number has barely shifted. Is the medicine working?

Almost certainly, yes. The 2.5mg dose is prescribed for one specific purpose: to introduce tirzepatide to your system gently enough that nausea, vomiting and other gastrointestinal effects stay manageable. It is the adjustment phase. Your prescriber will typically keep you at this level for four weeks before considering the step to 5mg, and weight loss is not the measure of success at this stage, tolerability is.

That does not mean nothing is happening. Tirzepatide is a dual GIP and GLP-1 receptor agonist, and even at the lowest dose it begins interacting with the gut-hormone pathways that regulate appetite and gastric emptying. Some people feel slightly less hungry, eat smaller portions without planning to, or notice they feel full sooner. For others the appetite effect is barely perceptible at 2.5mg. Both experiences are described in clinical practice, and neither predicts how well the medicine will work at higher doses.

The honest answer to the question on this page (will I lose weight on 2.5mg Mounjaro) is: probably a little, possibly none, and that is fine. The goal of this pen is not the destination.

What the trial evidence says about weight loss across the dose range

The clearest way to frame this is to look at what happened in SURMOUNT-1, the pivotal phase 3 trial that underpins Mounjaro's UK licence for weight management. Over 72 weeks, participants randomised to tirzepatide at the highest maintenance dose averaged around 20–21% body-weight reduction. That figure comes from the SURMOUNT-1 paper published in the New England Journal of Medicine, and it is widely cited in NICE's appraisal of tirzepatide.

Crucially, participants did not start at 15mg. Everyone began at 2.5mg and titrated upward in 4-week steps, exactly as the licensed schedule requires. The weight reductions that made headlines accumulated over many months at progressively higher doses. There is no shortcut through the starting phase, and there was never meant to be.

For practical context on what weight loss at 2.5mg looks like in more detail, it helps to know that the tolerability design is consistent across GLP-1 class medicines, the pattern of slower early loss followed by steeper reduction as the dose rises is well established.

One more thing worth saying plainly: even modest early weight loss, or none at all, does not mean the medicine is not working for you. The pharmacological effect is building, not absent.

Side effects at 2.5mg, and why they are a signal, not a problem

The most common experiences at the starting dose are gastrointestinal: nausea is the one people mention most, followed by loose stools, constipation (sometimes in the same week), burping and a general feeling of fullness that can feel uncomfortable at first. These effects are most pronounced in the days after injection and usually settle within a week or two as the body adapts. They tend to return, briefly, with each dose increase, which is the same mechanism at work again.

If you find the 2.5mg side effects difficult, that is useful clinical information for your prescriber. A slower titration is sometimes appropriate; staying at 2.5mg for eight weeks rather than four is not uncommon when tolerability needs more time. Conversely, if 2.5mg has been completely smooth and you are ready to move to the next dose, your prescriber will assess that at your follow-up review.

The NHS tirzepatide medicines page covers the full side-effect profile and the signs that need prompt medical attention, worth reading before your first injection if you have not already. Severe or persistent stomach pain that radiates to your back should be assessed urgently; it can occasionally indicate pancreatitis, a rare but recognised side effect across the GLP-1 class.

The side-effect picture at 2.5mg is also relevant to cost decisions. Some people wonder whether staying on the starter dose longer would reduce their medicine spend. It might, but that is a clinical question, not a financial one. Cost context for Mounjaro across the full dose range is covered on our Mounjaro price page, which also explains the significant UK list-price changes that took effect in September 2025.

What happens when the dose increases, and how to get there safely

Moving from 2.5mg to 5mg is typically where most people first notice meaningful appetite suppression and the scales beginning to respond. The step to 5mg tends to produce a more noticeable effect than the starter dose, and the titration continues from there if the higher dose is both tolerated and appropriate.

At each stage, a prescriber reviews your progress. At nume, that review happens before every repeat, a real clinician, not automated software, looks at your case. If you are wondering whether moving to 5mg will bring faster weight loss, the short answer is usually yes, though individual variation is real and the full picture takes months to emerge.

Some people ask whether rushing the titration would accelerate results. It would not; it would increase the likelihood of side effects severe enough to interrupt treatment, which is the opposite of helpful. The schedule exists because the trials that established Mounjaro's safety and effectiveness were built around it. Higher doses do tend to produce greater loss, but only when reached steadily.

If you are approaching a dose increase and unsure what to expect from the pen itself, our page on what the Mounjaro KwikPen looks like after four doses covers the practical side. And if you are still at the research stage, whether 2.5mg Mounjaro alone can produce meaningful loss addresses the question from a slightly different angle.

A note on timing: if you are planning to start treatment around a holiday or a period when you cannot refrigerate your pens reliably, mention that at consultation, it is a practical factor worth raising early. Start your free consultation with our clinical team when you are ready; our prescribers are available seven days a week for aftercare questions once treatment is underway.